Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 1,529 |
|
|||||
| News | - | ||||||
| Day High | 1.55 | Low High |
|||||
| Day Low | 1.5226 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cocrystal Pharma Inc | COCP | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0062 | 0.40% | 1.55 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.55 | 1.5226 | 1.55 | 1.55 | 1.5438 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 33 | 1,529 | US$ 1.55 | US$ 2,363 | - | 1.325 - 3.285 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:11:12 | 15 | US$ 1.58 | USD |
Cocrystal Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 15.77M | 10.17M | - | 2.6M | -17.98M | -1.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cocrystal Pharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/28/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Reports 2023 Financial Results and Provides.. |
| 3/19/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Receives Pre-IND Responses from the FDA on.. |
| 3/01/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/08/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/04/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/04/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Provides an Update on the Clinical.. |
| 1/02/2024 | 08:53 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 12/21/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/06/2023 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/06/2023 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Announces First-Patient-In for Phase 2a.. |
| 12/04/2023 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/29/2023 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COCP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.59 | 1.59 | 1.4885 | 1.55 | 7,590 | -0.04 | -2.52% |
| 1 Month | 1.51 | 1.67 | 1.35 | 1.52 | 12,990 | 0.04 | 2.65% |
| 3 Months | 1.53 | 1.74 | 1.325 | 1.49 | 13,857 | 0.02 | 1.31% |
| 6 Months | 1.59 | 1.99 | 1.325 | 1.63 | 16,233 | -0.04 | -2.52% |
| 1 Year | 2.44 | 3.285 | 1.325 | 2.18 | 22,886 | -0.89 | -36.48% |
| 3 Years | 14.40 | 41.52 | 1.325 | 19.16 | 1,834,457 | -12.85 | -89.24% |
| 5 Years | 30.96 | 49.20 | 1.325 | 18.89 | 2,024,396 | -29.41 | -94.99% |
Cocrystal Pharma Description
| Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). |
